2.47
Health Catalyst Inc stock is traded at $2.47, with a volume of 376.59K.
It is up +0.82% in the last 24 hours and down -5.36% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$2.45
Open:
$2.46
24h Volume:
376.59K
Relative Volume:
0.59
Market Cap:
$174.71M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-1.6467
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+8.33%
1M Performance:
-5.36%
6M Performance:
-38.71%
1Y Performance:
-66.44%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
2.47 | 173.29M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Surprises Report: Is Health Catalyst Inc stock a top pick in earnings seasonJuly 2025 Outlook & Verified Swing Trading Watchlists - moha.gov.vn
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - ulpravda.ru
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - ulpravda.ru
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - ulpravda.ru
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - ulpravda.ru
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - ulpravda.ru
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Stifel Nicolaus Reaffirms Their Hold Rating on Health Catalyst (HCAT) - The Globe and Mail
Signal Recap: Is Health Catalyst Inc stock oversold or undervaluedGap Down & Weekly High Return Stock Opportunities - moha.gov.vn
Investor Mood: Can Health Catalyst Inc stock rebound after recent weaknessWeekly Stock Analysis & Safe Entry Point Identification - moha.gov.vn
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Bollinger Band Squeeze Points to Volatility in Winsome Textile Industries LimitedOptions Trading Strategies & Fast Profit Capital Growth - earlytimes.in
What analysts say about Health Catalyst Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Health Catalyst Insider Ups Holding By 109% During Year - Yahoo Finance
Is Health Catalyst Inc. stock a buy before product launchesJuly 2025 Update & Weekly High Momentum Picks - Улправда
Health Catalyst, IncCommon stock (NQ: HCAT - FinancialContent
Will Health Catalyst Inc. (2YP) stock outperform global peersJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Why Health Catalyst Inc. stock is a must watch in 2025Market Performance Report & Momentum Based Trading Signals - Улправда
Would You Still Hold Health Catalyst Stock If It Fell 30%? - Trefis
Death Cross: How Health Catalyst Inc. stock trades during market volatility2025 Market Outlook & Community Shared Stock Ideas - Улправда
Is Health Catalyst Inc. (2YP) stock attractive for growth fundsTrade Analysis Summary & Community Supported Trade Ideas - Улправда
HubSpot, nCino, Rapid7, and Health Catalyst Stocks Trade Down, What You Need To Know - Finviz
New Innovation Program to Strengthen Community Health Tech Economy in Northwest Arkansas - PR Newswire
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares - MarketBeat
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock - MarketBeat
Dir Larson-Green Sells 47,997 ($128.3K) Of Health Catalyst Inc [HCAT] - TradingView — Track All Markets
Health Catalyst's Market Cap Drops To US$190m Leaving Insiders With Losses - simplywall.st
What technical patterns form on Health Catalyst Inc. (2YP) stock chartsWeekly Market Outlook & Precise Buy Zone Tips - Newser
How Health Catalyst Inc. (2YP) stock behaves in tightening cyclesLong Setup & Weekly Market Pulse Alerts - Newser
Is Health Catalyst Inc. (2YP) stock positioned for digital growth era2025 Market Overview & Fast Moving Stock Watchlists - Newser
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is Health Catalyst Inc. (2YP) stock supported by free cash flowWeekly Investment Summary & Stock Timing and Entry Methods - Newser
Why Health Catalyst Inc stock is a must watch in 2025 - BỘ NỘI VỤ
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 45% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews
Officer Freeman Surrenders 16,401 Of Health Catalyst Inc [HCAT] - TradingView
Will Health Catalyst Inc. (2YP) stock sustain bullish trend into 20252025 Technical Overview & Weekly High Return Forecasts - Newser
Health Catalyst appoints largest shareholder’s CEO to board By Investing.com - Investing.com Canada
Is Health Catalyst Inc. (2YP) stock expanding market penetrationJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Health Catalyst Q3 2025 Earnings Preview - MSN
Matt Arens, CEO and founder of Health Catalyst's largest shareholder, First Light Asset Management, joins board of directors - marketscreener.com
Matt Arens, CEO And Founder Of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board Of Directors - TradingView
Health Catalyst appoints largest shareholder’s CEO to board - Investing.com
Health Catalyst Appoints New Board Member Matt Arens - TipRanks
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Health Catalyst Inc Stock (HCAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Larson-Green Julie | Director |
Dec 04 '25 |
Sale |
2.67 |
47,997 |
128,349 |
73,573 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):